vs
Acadia Healthcare Company, Inc.（ACHC）与Arm（ARM）财务数据对比。点击上方公司名可切换其他公司
Arm的季度营收约是Acadia Healthcare Company, Inc.的1.5倍（$1.2B vs $829.0M），Arm净利率更高（18.0% vs 0.5%，领先17.4%），Arm同比增速更快（26.3% vs 7.5%），过去两年Arm的营收复合增速更高（24.1% vs 2.0%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
Arm Holdings 是一家总部位于英国剑桥的半导体与软件设计公司。公司设计 Arm CPU 架构，并将处理器设计与相关知识产权授权给全球的芯片厂商和设备制造商。基于 Arm 架构的芯片驱动着绝大多数智能手机，并在笔记本电脑、数据中心服务器和嵌入式设备中占据越来越大的份额。公司于 2023 年 9 月在纳斯达克上市，目前仍由软银控股。
ACHC vs ARM — 直观对比
营收规模更大
ARM
是对方的1.5倍
$829.0M
营收增速更快
ARM
高出18.8%
7.5%
净利率更高
ARM
高出17.4%
0.5%
两年增速更快
ARM
近两年复合增速
2.0%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $1.2B |
| 净利润 | $4.5M | $223.0M |
| 毛利率 | — | 97.6% |
| 营业利润率 | — | 14.9% |
| 净利率 | 0.5% | 18.0% |
| 营收同比 | 7.5% | 26.3% |
| 净利润同比 | -50.8% | -11.5% |
| 每股收益（稀释后） | $0.05 | $0.21 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCARM
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $1.2B | ||
| Q3 25 | $851.6M | $1.1B | ||
| Q2 25 | $869.2M | $1.1B | ||
| Q1 25 | $770.5M | — | ||
| Q4 24 | $774.2M | $983.0M | ||
| Q3 24 | $815.6M | $844.0M | ||
| Q2 24 | $796.0M | $939.0M |
净利润ACHCARM
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $223.0M | ||
| Q3 25 | $36.2M | $238.0M | ||
| Q2 25 | $30.1M | $130.0M | ||
| Q1 25 | $8.4M | — | ||
| Q4 24 | $32.6M | $252.0M | ||
| Q3 24 | $68.1M | $107.0M | ||
| Q2 24 | $78.5M | $223.0M |
毛利率ACHCARM
| Q1 26 | — | — | ||
| Q4 25 | — | 97.6% | ||
| Q3 25 | — | 97.4% | ||
| Q2 25 | — | 97.2% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 97.2% | ||
| Q3 24 | — | 96.2% | ||
| Q2 24 | — | 96.5% |
营业利润率ACHCARM
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 14.9% | ||
| Q3 25 | 4.7% | 14.4% | ||
| Q2 25 | 5.8% | 10.8% | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 4.9% | 17.8% | ||
| Q3 24 | 12.1% | 7.6% | ||
| Q2 24 | 13.4% | 19.4% |
净利率ACHCARM
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 18.0% | ||
| Q3 25 | 4.3% | 21.0% | ||
| Q2 25 | 3.5% | 12.3% | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 4.2% | 25.6% | ||
| Q3 24 | 8.4% | 12.7% | ||
| Q2 24 | 9.9% | 23.7% |
每股收益（稀释后）ACHCARM
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.21 | ||
| Q3 25 | $0.40 | $0.22 | ||
| Q2 25 | $0.33 | $0.12 | ||
| Q1 25 | $0.09 | — | ||
| Q4 24 | $0.36 | $0.24 | ||
| Q3 24 | $0.74 | $0.10 | ||
| Q2 24 | $0.85 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $3.5B |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $2.0B | $7.8B |
| 总资产 | $5.5B | $10.2B |
| 负债/权益比越低杠杆越低 | 1.29× | — |
8季度趋势，按日历期对齐
现金及短期投资ACHCARM
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $3.5B | ||
| Q3 25 | $118.7M | $3.3B | ||
| Q2 25 | $131.4M | $2.9B | ||
| Q1 25 | $91.2M | — | ||
| Q4 24 | $76.3M | $2.7B | ||
| Q3 24 | $82.1M | $2.4B | ||
| Q2 24 | $77.2M | $2.5B |
总债务ACHCARM
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
股东权益ACHCARM
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $7.8B | ||
| Q3 25 | $3.1B | $7.4B | ||
| Q2 25 | $3.1B | $7.0B | ||
| Q1 25 | $3.0B | — | ||
| Q4 24 | $3.1B | $6.4B | ||
| Q3 24 | $3.0B | $6.0B | ||
| Q2 24 | $3.0B | $5.7B |
总资产ACHCARM
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $10.2B | ||
| Q3 25 | $6.4B | $9.7B | ||
| Q2 25 | $6.3B | $9.4B | ||
| Q1 25 | $6.1B | — | ||
| Q4 24 | $6.0B | $8.5B | ||
| Q3 24 | $5.9B | $8.1B | ||
| Q2 24 | $5.7B | $7.9B |
负债/权益比ACHCARM
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | $365.0M |
| 自由现金流经营现金流 - 资本支出 | — | $186.0M |
| 自由现金流率自由现金流/营收 | — | 15.0% |
| 资本支出强度资本支出/营收 | — | 14.4% |
| 现金转化率经营现金流/净利润 | 13.78× | 1.64× |
| 过去12个月自由现金流最近4个季度 | — | $1.2B |
8季度趋势，按日历期对齐
经营现金流ACHCARM
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $365.0M | ||
| Q3 25 | $73.2M | $567.0M | ||
| Q2 25 | $133.5M | $332.0M | ||
| Q1 25 | $11.5M | — | ||
| Q4 24 | $116.7M | $423.0M | ||
| Q3 24 | $163.1M | $6.0M | ||
| Q2 24 | $171.1M | $-290.0M |
自由现金流ACHCARM
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $186.0M | ||
| Q3 25 | $-63.0M | $429.0M | ||
| Q2 25 | $-34.2M | $178.0M | ||
| Q1 25 | $-163.2M | — | ||
| Q4 24 | $-86.8M | $360.0M | ||
| Q3 24 | $-27.1M | $-47.0M | ||
| Q2 24 | $16.9M | $-319.0M |
自由现金流率ACHCARM
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 15.0% | ||
| Q3 25 | -7.4% | 37.8% | ||
| Q2 25 | -3.9% | 16.9% | ||
| Q1 25 | -21.2% | — | ||
| Q4 24 | -11.2% | 36.6% | ||
| Q3 24 | -3.3% | -5.6% | ||
| Q2 24 | 2.1% | -34.0% |
资本支出强度ACHCARM
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 14.4% | ||
| Q3 25 | 16.0% | 12.2% | ||
| Q2 25 | 19.3% | 14.6% | ||
| Q1 25 | 22.7% | — | ||
| Q4 24 | 26.3% | 6.4% | ||
| Q3 24 | 23.3% | 6.3% | ||
| Q2 24 | 19.4% | 3.1% |
现金转化率ACHCARM
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 1.64× | ||
| Q3 25 | 2.02× | 2.38× | ||
| Q2 25 | 4.43× | 2.55× | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | 1.68× | ||
| Q3 24 | 2.39× | 0.06× | ||
| Q2 24 | 2.18× | -1.30× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
ARM
| Royalty | $737.0M | 59% |
| Transferred Over Time | $294.0M | 24% |
| Transferred At Point In Time | $211.0M | 17% |
